Caption Management, LLC Tyra Biosciences, Inc. Transaction History
Caption Management, LLC
- $5.74 Billion
- Q3 2024
A detailed history of Caption Management, LLC transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Caption Management, LLC holds 67,500 shares of TYRA stock, worth $1.09 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
67,500Holding current value
$1.09 Million% of portfolio
0.03%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding TYRA
# of Institutions
98Shares Held
43.5MCall Options Held
353KPut Options Held
1.1K-
Ra Capital Management, L.P. Boston, MA10.4MShares$169 Million3.41% of portfolio
-
Boxer Capital, LLC San Diego, CA6.45MShares$104 Million8.05% of portfolio
-
Bvf Inc San Francisco, CA4.66MShares$75.5 Million3.48% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.41MShares$71.4 Million97.89% of portfolio
-
Nextech Invest Ag4.06MShares$65.7 Million15.55% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $680M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...